Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exagen (XGN) EBT Margin (2018 - 2025)

Exagen (XGN) has disclosed EBT Margin for 8 consecutive years, with 37.65% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT Margin fell 1020.0% year-over-year to 37.65%, compared with a TTM value of 32.3% through Dec 2025, down 515.0%, and an annual FY2025 reading of 29.89%, down 275.0% over the prior year.
  • EBT Margin was 37.65% for Q4 2025 at Exagen, up from 41.09% in the prior quarter.
  • Across five years, EBT Margin topped out at 19.69% in Q2 2024 and bottomed at 192.87% in Q2 2022.
  • Average EBT Margin over 5 years is 55.61%, with a median of 40.73% recorded in 2023.
  • The sharpest move saw EBT Margin plummeted -14269bps in 2022, then skyrocketed 15741bps in 2023.
  • Year by year, EBT Margin stood at 54.2% in 2021, then plummeted by -117bps to 117.76% in 2022, then surged by 66bps to 40.25% in 2023, then skyrocketed by 32bps to 27.46% in 2024, then tumbled by -37bps to 37.65% in 2025.
  • Business Quant data shows EBT Margin for XGN at 37.65% in Q4 2025, 41.09% in Q3 2025, and 25.59% in Q2 2025.